---
schema_version: "secwatch.filing_event.v1"
accession: "0001636422-22-000038"
form_type: "8-K"
ticker: "HCAT"
cik: "0001636422"
company_name: "Health Catalyst, Inc."
filed_at: "2022-08-04T23:59:59+00:00"
generated_at: "2026-06-24T04:11:56.103520+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Health Catalyst Q2 revenue up 18% to $70.6M; lowers full-year guidance

## Summary
- Total revenue $70.6M, up 18% YoY; Technology revenue $45.4M (+28%), Professional services $25.2M (+5%).
- GAAP net loss $33.4M vs $35.8M loss a year ago; Adjusted EBITDA $2.0M, up 20%.
- Adjusted Technology Gross Margin 70%, Adjusted Professional Services Gross Margin 27%.
- Revising down full-year 2022 revenue and Adjusted EBITDA outlook citing challenging end-market environment.

## SEC filing metadata
- accession: 0001636422-22-000038
- form_type: 8-K
- ticker: HCAT
- cik: 0001636422
- company_name: Health Catalyst, Inc.
- filed_at: 2022-08-04T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1636422/000163642222000038/0001636422-22-000038-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1636422/000163642222000038/hcat-20220804.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001636422-22-000038
- JSON: https://secwatch.observer/filing/0001636422-22-000038.json
- Plain text: https://secwatch.observer/filing/0001636422-22-000038.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.